Gilead Sciences, Inc. announced that the FDA approved Bixlenvo (bictegravir 75 mg/lenacapavir 50 mg), the smallest once-daily single tablet regimen (STR) for the treatment of HIV in adults… read more.
Takeda announced FDA approval of the New Drug Application (NDA) for Mimrylo (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. Mimrylo… read more.
An experimental cancer drug could stop osteoporosis and help women stay slim after the menopause – according to new research from the University of East Anglia. A study… read more.
Three large studies together show that, although the number of people who smoke is declining, people are taking up smoking at a younger age and vaping has increased,… read more.
HUTCHMED (China) announces that the New Drug Application (NDA) for fanregratinib (HMPL-453), a novel, selective, oral inhibitor targeting FGFR 1/2/3, has been granted conditional approval by the China… read more.
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation announced the FDA has approved BESREMi (ropeginterferon alfa-2b-njft) for the treatment of adults with essential thrombocythemia (ET), making it the… read more.
In a third of cases, AI chatbots wrongly reassure sleep apnoea patients that their symptoms are not serious, discouraging them from seeking a referral to a specialist, according… read more.
Men already at risk genetically for the most common form of hair loss have a 7 percent added risk of losing their hair if they use drugs like… read more.
Roche announced new two-year data from the Phase IIIb/IV SALWEEN study of Vabysmo (faricimab), presented at the 19th Asia-Pacific Vitreo-retina Society (APVRS) Congress in Australia. The results showed… read more.
Bristol Myers Squibb presented results from the EXPLORER-LTE cohort of the MAVA-LTE study (NCT03723655) at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. EXPLORER-LTE is… read more.
Robot-assisted knee replacement surgery is more precise than a surgeon on their own, but does not currently lead to improvements in patient outcomes, according to the RACER-Knee trial,… read more.
Automatic crash notification (ACN) systems should become a standard safety feature in every new vehicle, like seat belts and air bags, according to a new paper by members of the American… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
